Neovascular Age Related Macular Degeneration (AMD), Periocular Corticosteroids, and Photodynamic Therapy (PDT)
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
Randomized controlled clinical trial of periocular corticosteroids as adjunctive therapy to
photodynamic therapy (PDT) for patients with neovascular age-related macular degeneration
(AMD). Patients undergoing PDT are randomized to either a periocular corticosteroid injection
with 40 mg of triamcinolone acetonide or observation just prior to PDT. Patients are followed
for 6 months. Primary outcome is leakage from choroidal neovascularization (CNV) at 3 months
on fluorescein angiography.